Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
- Status
- COMPLETED
- Phase
- PHASE3
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
- Status
- TERMINATED
- Phase
- PHASE1
Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)
- Status
- COMPLETED
- Phase
- PHASE3
Alefacept for Prevention of Graft Versus Host Disease (GVHD)
- Status
- TERMINATED
- Phase
- PHASE3
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
- Status
- TERMINATED
- Phase
- NA
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Transplantation From Related Haploidentical Donors
- Status
- COMPLETED
- Phase
- PHASE2
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3